Apellis Pharmaceuticals (NASDAQ:APLS) Given “Buy” Rating at HC Wainwright
HC Wainwright restated their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research note published on Monday,Benzinga reports. HC Wainwright currently has a $57.00 price objective on the stock. A number of other brokerages have also commented on APLS. Citigroup dropped their price objective on shares of Apellis Pharmaceuticals from […]
HC Wainwright restated their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research note published on Monday,Benzinga reports. HC Wainwright currently has a $57.00 price objective on the stock. A number of other brokerages have also commented on APLS. Citigroup dropped their price objective on shares of Apellis Pharmaceuticals from […]
